Dear Colleagues and Friends,
We are excited to welcome you to the EuroACTOS Meeting 2025, a unique collaboration that merges the well-established Euro CTO Meeting and the ACTOS Meeting from Amsterdam. This joint event will be held on September 11th and 12th at the World Trade Center in Rotterdam.
This year, we gather in the vibrant and innovative city of Rotterdam to continue advancing the treatment of chronic total occlusion (CTO). The Euro CTO Meeting boasts a rich scientific heritage and has been a leader in CTO treatment for years, driving groundbreaking advancements, fostering innovation, and facilitating the exchange of best practices among interventional cardiologists worldwide. Likewise, the ACTOS Meeting, with its roots in Amsterdam, has established itself as a premier international CTO course, recognized for its emphasis on technique, precision, and practical education. Together, these platforms create an unparalleled opportunity to push the boundaries of CTO recanalization and patient care.
Our program is meticulously designed to provide a comprehensive and immersive learning experience. A particular highlight will be the live case demonstrations, featuring transmissions from Amsterdam and Rotterdam. These cases, conducted by some of the world’s most skilled operators, will showcase the latest techniques and technologies in CTO treatment. Expert lectures, interactive discussions, and real-world insights from global thought leaders will further enhance the scientific and educational value of the meeting.
The EuroACTOS Meeting 2025 offers not only an opportunity to engage with peers and leaders in the field but also a chance to contribute to the ongoing advancement of CTO treatment. By blending the scientific rigor of the Euro CTO Meeting with the hands-on educational focus of ACTOS, this event promises to deliver an exceptional experience for all attendees.
We look forward to welcoming you to Rotterdam for an inspiring and scientifically enriching meeting that will enhance your knowledge, skills, and passion for the treatment of CTO.
Best regards,